HHS Price Negotiation Under Medicare Rx Would Not Beat PBM Prices – CMS
Executive Summary
HHS price negotiations for the Medicare drug benefit would not yield greater savings than health plans will be able to secure because the government would be unlikely to use its negotiating power forcefully enough, Centers for Medicare & Medicaid Services Chief Actuary Richard Foster says
You may also be interested in...
Sebelius Draws Parallels Between Her State Experience And HHS Tasks Ahead
Over the course of two non-contentious hearings to discuss her nomination as HHS secretary, Kansas governor Kathleen Sebelius drew many comparisons between some of the tasks envisioned through health care reform and her work at the state level
Sebelius Draws Parallels Between Her State Experience And HHS Tasks Ahead
Over the course of two non-contentious hearings to discuss her nomination as HHS secretary, Kansas governor Kathleen Sebelius drew many comparisons between some of the tasks envisioned through health care reform and her work at the state level
PhRMA Launching National Patient Assistance Clearinghouse April 5
The Pharmaceutical Research & Manufacturers of America's "Partnership for Patient Assistance" clearinghouse for prescription drug support programs will roll out nationwide April 5